Pharmaceutical

Boehringer and Lilly gain FDA approval for kidney disease therapy

Boehringer and Eli Lilly have received approval from the US FDA for Jardiance to treat adults with chronic kidney disease (CKD).

Sep 25, 2023 - 20:00
Boehringer and Lilly gain FDA approval for kidney disease therapy
Boehringer and Eli Lilly have received approval from the US FDA for Jardiance to treat adults with chronic kidney disease (CKD).
Read the original article

Tags:

Previous Article

Merck and ICR enter renewed cancer drug discovery partnership

Next Article

A novel role discovered for vagus nerve

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sweeping bill to fight opioid addiction will be considered by Senate health committee

Sweeping bill to fight opioid addiction will be conside...

Dec 5, 2023

Is there a bigger move being planned at Cigna?

Is there a bigger move being planned at Cigna?

Nov 13, 2023

STAT+: Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation

STAT+: Pharmalittle: Weight-loss drug makers lobby Cong...

Apr 25, 2023